Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer

Table 5

The differential expression, differential translation efficiency, or differential methylation genes upon perturbation of WERs.

Perturbation
Species	Cell line	Class	WER name	Target gene	Interaction	Downstream effect
Human	HeLa	Writer	VIRMA	LMAN2	Protein-protein	Methylation
Human	HeLa	Writer	HAKAI	LMAN2	No evidence	Expression
Human	HepG2	Writer	METTL3	LMAN2	No evidence	Expression
Human	HeLa	Writer	WTAP	LMAN2	No evidence	Methylation
Human	A549	Writer	VIRMA	LMAN2	No evidence	Methylation
Human	A549	Writer	WTAP	LMAN2	No evidence	Methylation
Human	Mono-Mac-6	Eraser	FTO	LMAN2	No evidence	Methylation
Human	HeLa	Writer	ZC3H13	LMAN2	No evidence	Methylation
Human	HeLa	Writer	METTL3	LMAN2	No evidence	Methylation; translation
Human	HeLa	Writer	VIRMA	LMAN2	Protein-protein	Methylation
Human	HeLa	Writer	HAKAI	LMAN2	No evidence	Expression
Human	HepG2	Writer	METTL3	LMAN2	No evidence	Expression
Human	HeLa	Writer	WTAP	LMAN2	No evidence	Methylation
Human	A549	Writer	VIRMA	LMAN2	No evidence	Methylation

WERs: writers, erasers, and readers. “Protein-protein” means targets summarized from mass spectroscopy results.